Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-25 @ 9:45 PM
Study NCT ID:
NCT05555251
Status:
TERMINATED
Last Update Posted:
2024-12-16
First Post:
2022-09-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors
Sponsor:
BioInvent International AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-22
First Submit QC Date:
None
Study First Post Date:
2022-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-10
Last Update Post Date:
2024-12-16
Last Update Post Date Type:
ACTUAL